WallStreetZenWallStreetZen

NASDAQ: CUE
Cue Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cue Biopharma earnings were -$164.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CUE earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$153.1M, up 2,856.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CUE reported annual earnings of -$26.6M, with -34.6% growth.

CUE earnings history

Current Revenue
$37.7M
Current Earnings
-$164.1M
Current Profit Margin
-435.8%

CUE Return on Equity

Current Company
-1,032.2%
Current Industry
-13.5%
Current Market
29%
CUE's Return on Equity (-1,032.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CUE Return on Assets

Current Company
-484.7%
Current Industry
-10.3%
CUE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CUE announces earnings.

CUE Return on Capital Employed

Current Company
-1,722.76%
Current Industry
-6.7%
CUE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CUE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CUE-$160.33M-$164.11MN/A-$26.42
NKTX-$105.57M-$117.32MN/A-$1.57
CNTN-$115.18M-$98.12MN/A-$0.12
INDP-$15.42M-$15.42MN/A-$6.33
CDXS-$16.48M-$30.72MN/A-$0.33
View Top Biotech Stocks

Cue Biopharma Earnings Reports & History FAQ

What were Cue Biopharma's earnings last quarter?

On CUE's earnings call on Aug 18, 2026, Cue Biopharma (NASDAQ: CUE) reported Q2 2026 earnings per share (EPS) of -$24.14, up 804.12% year over year. Total CUE earnings for the quarter were -$153.07 million. In the same quarter last year, Cue Biopharma's earnings per share (EPS) was -$2.67.

If you're new to stock investing, here's how to buy Cue Biopharma stock.

Is Cue Biopharma profitable or losing money?

As of the last Cue Biopharma earnings report, Cue Biopharma is currently losing money. Cue Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$164.11 million, a 321.93% increase year over year.

What was CUE's earnings growth in the past year?

As of Cue Biopharma's earnings date in Aug 18, 2026, Cue Biopharma's earnings has grown year over year. CUE earnings in the past year totalled -$164.11 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.